No Data
No Data
Press Release: Cannara Biotech Inc. Reports Q4 and Fiscal Year 2024 Results: Achieves Record Sales Growth and Operating Cash Flow, Solidifying Leadership in Canada's Cannabis Market
Cannara Biotech Inc.'s (CVE:LOVE) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Cannara Biotech Achieves Its Highest National Market Share of 3.2% in July 2024 and Announces Investor Webcast Scheduled for August 20, 2024
Cannara Biotech Turns Negative As Reports Wider Q2 Net Loss Vs a Year Ago, Despite Revenue up 51%
Press Release: Cannara Biotech Reports Q2 2024 Financial Results
Cannara Biotech Announces Record-Breaking Q1 2024 Results: Continued Robust Growth and Market...
No Data